These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 15958072

  • 1. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW, Cole D, Jiang WZ, Jin HT, Fu N, Chen ZL, Jin NY.
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [Abstract] [Full Text] [Related]

  • 2. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG, Liou RS, Sun LK, Yu LM, Starnes SM, Fung MS, Chang TW, Chang NT.
    Hum Antibodies Hybridomas; 1994 Jul; 5(1-2):9-17. PubMed ID: 7858187
    [Abstract] [Full Text] [Related]

  • 3. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F, Bergami PL, Duval M, Kuhrt D, Posner M, Cavacini L.
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
    Matsushita S, Maeda H, Kimachi K, Eda Y, Maeda Y, Murakami T, Tokiyoshi S, Takatsuki K.
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
    [Abstract] [Full Text] [Related]

  • 5. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J, Pope T, Tung JS, Chan C, Hollis G, Mark G, Johnson KS.
    J Mol Biol; 1996 Feb 16; 256(1):77-88. PubMed ID: 8609615
    [Abstract] [Full Text] [Related]

  • 6. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies.
    van der Donk EM, Schutten M, Osterhaus AD, van der Heijden RW.
    AIDS Res Hum Retroviruses; 1994 Dec 01; 10(12):1639-49. PubMed ID: 7888223
    [Abstract] [Full Text] [Related]

  • 8. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
    Laman JD, Schellekens MM, Paddenburg D, Tersmette M, Langedijk JP, Boersma WJ, Claassen E.
    Year Immunol; 1993 Dec 01; 7():63-8. PubMed ID: 7690509
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Importance of conformation on the neutralizing antibody response to HIV-1 gp120.
    Steimer KS, Haigwood NL.
    Biotechnol Ther; 1991 Dec 01; 2(1-2):63-89. PubMed ID: 1726963
    [Abstract] [Full Text] [Related]

  • 12. Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.
    Duarte CA, Montero M, Seralena A, Valdés R, Jiménez V, Benítez J, Narciandi E, Madrazo J, Padrón G, Sánchez G.
    AIDS Res Hum Retroviruses; 1994 Mar 01; 10(3):235-43. PubMed ID: 7517147
    [Abstract] [Full Text] [Related]

  • 13. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
    Neshat MN, Goodglick L, Lim K, Braun J.
    Int Immunol; 2000 Mar 01; 12(3):305-12. PubMed ID: 10700465
    [Abstract] [Full Text] [Related]

  • 14. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K, Farnaes L, Wang M, Svejgaard A, Burton DR, Ditzel HJ.
    J Immunol Methods; 2005 Feb 01; 297(1-2):187-201. PubMed ID: 15777942
    [Abstract] [Full Text] [Related]

  • 15. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Feb 01; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 16. Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci.
    He Y, Honnen WJ, Krachmarov CP, Burkhart M, Kayman SC, Corvalan J, Pinter A.
    J Immunol; 2002 Jul 01; 169(1):595-605. PubMed ID: 12077293
    [Abstract] [Full Text] [Related]

  • 17. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 18. Optimization of a fed-batch process for production of a recombinant antibody.
    Robinson DK, Seamans TC, Gould SL, DiStefano DJ, Chan CP, Lee DK, Bibila T, Glazomitsky K, Munshi S, Daugherty B.
    Ann N Y Acad Sci; 1994 Nov 30; 745():285-96. PubMed ID: 7832519
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human antibodies to HIV-1 by recombinant DNA methods.
    Burton DR, Barbas CF.
    Chem Immunol; 1993 Nov 30; 56():112-26. PubMed ID: 8452652
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.